MedWatch

Joe Biden hopes to end "outrageous" insulin prices

Like his predecessor and other prominent US politicians, President Joe Biden has targeted the price for insulin treatments. Having been passed in the House of Representatives, Biden's new bill only needs to find backing in the Senate.

US President Joe Biden | Photo: Kevin Lamarque/Reuters/Ritzau Scanpix

Insulin treatment prices in the US have long been targeted by US politicians across party lines.

The latest to join the party is President Joe Biden, who wants to launch initiatives to put a cap on insulin prices. On Monday, he repeated this goal in a tweet, in which he calls prices around USD 1,000 "outrageous" for the vital insulin treatments.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

"Real world" patient data documents the long-term effects of ALK vaccines

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers. 

Further reading

Related articles

Latest news

See all jobs